Cowen Inc. bought a new stake in Herbalife Ltd. (NYSE:HLF) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 118,300 shares of the company’s stock, valued at approximately $8,025,000. Cowen Inc. owned about 0.14% of Herbalife as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pacad Investment Ltd. purchased a new stake in shares of Herbalife during the 2nd quarter valued at approximately $1,283,000. FMR LLC lifted its stake in shares of Herbalife by 9.1% during the 2nd quarter. FMR LLC now owns 8,025,946 shares of the company’s stock valued at $572,490,000 after buying an additional 667,474 shares in the last quarter. Oberndorf William E lifted its stake in shares of Herbalife by 34.9% during the 3rd quarter. Oberndorf William E now owns 195,660 shares of the company’s stock valued at $13,272,000 after buying an additional 50,660 shares in the last quarter. CIBC World Markets Inc. purchased a new stake in shares of Herbalife during the 2nd quarter valued at approximately $4,924,000. Finally, William Blair Investment Management LLC lifted its stake in shares of Herbalife by 10.8% during the 2nd quarter. William Blair Investment Management LLC now owns 214,322 shares of the company’s stock valued at $15,288,000 after buying an additional 20,903 shares in the last quarter.
Herbalife Ltd. (NYSE:HLF) traded down $0.35 during trading on Thursday, reaching $67.64. 785,400 shares of the company were exchanged, compared to its average volume of 1,213,237. The company has a quick ratio of 2.24, a current ratio of 2.65 and a debt-to-equity ratio of 9.94. The company has a market cap of $5,928.54, a price-to-earnings ratio of 14.88 and a beta of 1.27. Herbalife Ltd. has a twelve month low of $47.70 and a twelve month high of $79.64.
A number of analysts recently commented on the stock. ValuEngine upgraded shares of Herbalife from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, November 22nd. Pivotal Research restated a “buy” rating and set a $120.00 price target on shares of Herbalife in a research note on Thursday, August 31st. Tigress Financial restated a “buy” rating on shares of Herbalife in a research note on Wednesday, August 9th. Zacks Investment Research cut shares of Herbalife from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Finally, SunTrust Banks reaffirmed a “hold” rating and set a $67.00 target price on shares of Herbalife in a report on Friday, November 10th. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $83.25.
WARNING: This piece of content was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/12/07/cowen-inc-invests-8-03-million-in-herbalife-ltd-hlf-stock.html.
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. Its operating segments are based on geographical operations in six regions: North America; Mexico; South and Central America; Europe, the Middle East, and Africa (EMEA); Asia Pacific, and China.
Receive News & Ratings for Herbalife Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.